Position in RYTM
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$40,414
+$17,194 QoQ
Shares Held
364
+36.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#248
of 299 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GAMMA Investing LLC holds $18,803,269 across 254 Biotechnology names. RYTM ranks #68 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,918 | $3,436,378 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,067 | $1,288,857 | |
| 3 | MRNA |
Moderna, Inc.
|
14,479 | $1,013,964 | |
| 4 | INCY |
Incyte Corp
|
8,213 | $931,025 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,769 | $619,529 | |
| 6 | EXEL |
Exelixis, Inc.
|
11,025 | $599,870 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
14,637 | $518,003 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
4,640 | $403,448 |
All Filings in RYTM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,414 | 364 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $23,220 | 267 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $38,641 | 361 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $24,540 | 243 | Shares | Defined | 2025-10-02 | |
| 2025-06-30 | $13,333 | 211 | Shares | Defined | 2025-07-14 | |
| 2025-03-31 | $14,884 | 281 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $11,251 | 201 | Shares | Defined | 2025-01-03 | |
| 2024-09-30 | $6,339 | 121 | Shares | Defined | 2024-10-07 | |
| 2024-06-30 | $3,366 | 82 | Shares | Defined | 2024-07-02 | |
| 2024-03-31 | $1,213 | 28 | Shares | Defined | 2024-04-05 | |
| 2023-12-31 | $597 | 13 | Shares | Defined | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||